Tag: oxycodone drugs market drivers

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

 

What is the Expected Growth Rate of the Oxycodone Drugs Market from 2024 to 2033?
The oxycodone drugs market has shown strong growth, expected to increase from $5.25 billion in 2023 to $5.62 billion in 2024, with a CAGR of 7.0%. Contributing factors include aggressive marketing, increased prescriptions for chronic pain, and the introduction of synthetic opiates post-World War II.

The oxycodone drugs market is expected to see strong growth, reaching $7.41 billion in 2028 at a CAGR of 7.2%. Growth factors include the rising prevalence of chronic pain, an increase in surgical procedures, ongoing product development, advancements in drug delivery systems, and a growing aging population. Major trends include demand for abuse-deterrent formulations, development of novel delivery systems, combination therapies, and technological advancements in manufacturing.

Claim Your Free Sample of the Global Oxycodone Drugs Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=15886&type=smp

What Key Factors Are Fueling the Growth of the Oxycodone Drugs Market?
The high burden of orthopedic disorders is expected to fuel the oxycodone drug market. Orthopedic disorders encompass various musculoskeletal conditions that lead to pain and functional limitations. The increasing incidence of these disorders is due to an aging population, sedentary lifestyles, obesity, and sports injuries. Oxycodone is used to manage acute and chronic pain from conditions such as fractures and post-surgical discomfort, effectively targeting the central nervous system’s pain receptors. For example, in October 2023, the IHME projected a 115% increase in musculoskeletal disorder cases from 2020 to 2050, reaching about 1,060 million prevalent cases. Therefore, the burden of orthopedic disorders is driving the growth of the oxycodone drug market.

What Are the Major Segments of the Oxycodone Drugs Market?
1) By Drug Type: Short Acting Oxycodone, Long Acting Oxycodone
2) By Dosage Form: Tablets, Capsules, Injections
3) By Indication: Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Post Operative Pain, Other Indications
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What New Trends Are Transforming the Oxycodone Drugs Market?
Major companies in the oxycodone drug market are focusing on creating innovative formulations like oxycodone immediate-release tablets to reduce misuse. For instance, in July 2022, Protega Pharmaceuticals launched RoxyBond (oxycodone) IR tablets, designed to deter abuse and misuse, demonstrating lower potential for abuse than traditional formulations.

Order Now for Fast Delivery of Your Oxycodone Drugs Market Report!
https://www.thebusinessresearchcompany.com/report/oxycodone-drugs-global-market-report

Which Regions Are Driving Growth in the Oxycodone Drugs Market?
North America was the largest region in the oxycodone drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oxycodone drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The Oxycodone Drugs Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the oxycodone drugs market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Oxycodone Drugs Market Include

1. Oxycodone Drugs Market Executive Summary
2. Oxycodone Drugs Market Segments
3. Oxycodone Drugs Market Size And Template Market Growth Rate
4. Key Oxycodone Drugs Market Trends
5. Major Oxycodone Drugs Market Drivers
……
25. Key Mergers And Acquisitions In The Oxycodone Drugs Market
26. Top Oxycodone Drugs Companies
27. Oxycodone Drugs Market Opportunities And Strategies
28. Oxycodone Drugs Market, Conclusions And Recommendations
29. Appendix

Discover Related Reports by The Business Research Company:
Narcotic Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/narcotic-drugs-global-market-report

Focal Segmental Glomerulosclerosis Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/focal-segmental-glomerulosclerosis-drugs-global-market-report

Antiparasitic Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/antiparasitic-drugs-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

 

The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

Market Overview: Strong Growth Trajectory

• Significant Market Expansion: The oxycodone drugs market has seen robust growth, with market size increasing from $5.25 billion in 2023 to an anticipated $5.62 billion in 2024, reflecting a CAGR of 7.0%.
• Historical Drivers: This growth is largely due to aggressive marketing campaigns, especially for OxyContin, which was heavily promoted for both chronic non-malignant pain and cancer-related pain. Post-World War II, the introduction of synthetic opiates like oxycodone further fueled market demand.

Future Outlook: Continued Growth and Innovations

• Forecasted Growth: The oxycodone drugs market is expected to grow to $7.41 billion by 2028, at a CAGR of 7.2%.
• Key Growth Drivers:
  • Increasing prevalence of chronic pain.
  • Rising number of surgical procedures.
  • Advancements in drug delivery systems.
  • A growing elderly population, which experiences higher incidences of chronic pain.
• Emerging Trends:
  • Development of abuse-deterrent formulations (ADFs).
  • Innovations in drug delivery systems.
  • Growing use of combination therapies.
  • Technological advancements in manufacturing.

Read More On The Oxycodone Drugs Market Report 2024 – https://www.thebusinessresearchcompany.com/report/oxycodone-drugs-global-market-report

Orthopedic Disorder Surge Fuels Market Growth

• High Burden of Orthopedic Disorders: The rising incidence of orthopedic conditions due to aging populations, sedentary lifestyles, and other factors is driving demand for oxycodone drugs.
• Impact on Market:
  • Oxycodone is used to alleviate pain from fractures, joint injuries, and post-surgical discomfort.
  • A significant increase in musculoskeletal disorders is expected, with projected cases rising by 115% from 2020 to 2050, reaching over 1 billion cases by 2050.

Focus on Developing Immediate-Release Tablets to Combat Drug Abuse

• Innovative Drug Development: Companies in the oxycodone market are focusing on creating formulations that reduce the potential for abuse.
• Key Example:
  • In July 2022, Protega Pharmaceuticals launched RoxyBond, an FDA-approved immediate-release oxycodone tablet designed to deter abuse through physical and chemical resistance.

UNC Kenan-Flagler and Acadia Healthcare Partner to Combat Opioid Crisis

• Strategic Partnership: In February 2023, UNC Kenan-Flagler Business School and Acadia Healthcare collaborated to create an opioid settlement playbook, aiming to guide communities in effectively using funds from opioid settlements.
• Objective:
  • The partnership focuses on optimizing the use of settlement funds for opioid recovery efforts, particularly in communities affected by the opioid crisis.

Market Segmentation and Regional Insights

• Segmentation:
  • By Drug Type: Short-acting oxycodone, long-acting oxycodone.
  • By Dosage Form: Tablets, capsules, injections.
  • By Indication: Neuropathic pain, musculoskeletal pain, cancer pain, post-operative pain, other indications.
  • By Distribution Channel: Hospital pharmacies, retail pharmacies, online pharmacies.
• Regional Insights:
  • North America was the largest market in 2023.
  • Asia-Pacific is expected to be the fastest-growing region during the forecast period.

Key Players in the Market

• Leading Companies: The market is dominated by major pharmaceutical players such as Pfizer Inc., Johnson & Johnson, Teva Pharmaceutical Industries, Purdue Pharma, and others.

The oxycodone drugs market is set for significant growth, driven by increasing demand due to chronic pain, innovations in drug delivery, and strategic partnerships aimed at addressing the opioid crisis.

Request for A Sample Of The Global Oxycodone Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=15886&type=smp